Abstract
TUMOUR necrosis factor (TNF), jointly referring to TNFα and TNFβ , is a central mediator of immune and inflammatory responses; its activities are mediated by two distinct receptors, TNFR1 (p55) and TNFR2 (p75) (reviewed in refs 1–3). The cyto-plasmic domains of the TNFRs are unrelated, suggesting that they link to different intracellular signalling pathways4. Although most TNF responses have been assigned to one or the other of the TNF receptors (mostly TNFR1), there is no generally accepted model for the physiological role of the two receptor types. To investigate the role of TNFR1 in beneficial and detrimental activities of TNF, we generated TNFR1-deficient mice by gene targeting. We report here that mice homozygous for a disrupted Tnfr l allele (Tnfr10) are resistant to the lethal effect of low doses of lipopolysaccharide after sensitization with D-galactosamine, but remain sensitive to high doses of lipopolysaccharide. The increased susceptibility of Tnfr10Tnfr10 mutant mice to infection with the facultative intracellular bacterium Listeria monocytogenes indicates an essential role of TNF in nonspecific immunity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Beutler, B. Tumour Necrosis Factor: the Molecules and their Emerging Role in Medicine (Raven, New York, 1992).
Aggarwal, B. & Vilcek, J. Tumour Necrosis Factors: Structure, Function, and Mechanism of Action (Marcel Dekker, New York, 1992).
Fiers, W. FEBS Lett. 285, 199–212 (1991).
Dembic, Z. et al. Cytokine 2, 231–237 (1990).
Rothe, J., Bluethmann, H., Gentz, R., Lesslauer, W. & Steinmetz, M. Molec. Immun. 30, 165–175 (1993).
Banner, D. W. et al. Cell 73, 1–20 (1993).
Lewis, M. et al. Proc. natn. Acad. Sci. U.S.A. 88, 2830–2834 (1991).
Bone, R. C. et al. Chest 101, 1644–1655 (1992).
Galanos, C., Freudenberg, M. A. & Reutter, W. Proc. natn. Acad. Sci. U.S.A. 76, 5939–5943 (1979).
Freudenberg, M. A. & Galanos, C. Infect. Immun. 59, 2110–2115 (1993).
Lesslauer, W. et al. Eur J. Immun. 21, 2883–2886 (1991).
Ashkenazi, A. et al. Proc. natn. Acad. Sci. U.S.A. 88, 10535–10539 (1991).
Waage, A. & Espevik, T. J. exp. Med. 169, 1987–1992 (1988).
Brouckaert, P., Libert, C., Everaerdt, B. & Fiers, W. Lymph. Cyt. Res. 11, 193–196 (1992).
Waage, A. et al. J. exp. Med. 170, 1859–1867 (1989).
Shalaby, R., Waage, A., Aarden, L. & Espevik, T. Clin. Immun. Immunopath. 53, 488–498 (1989).
Fong, Y. et al. J. exp. Med. 170, 1627–1633 (1989).
Havell, E. A. J. Immun. 139, 4225–4231 (1988).
Nakane, A., Minagawa, T. & Kato, K. Infect. Immun. 56, 2563–2569 (1988).
Hauser, T., Frei, K., Zinkernagel, R. M. & Leist, T. P. Med. microbiol. Immun. 179, 95–104 (1990).
Huang, S. et al. Science 259, 1742–1745 (1993).
Wong, G. H. & Goeddel, D. V. Nature 323, 819–822 (1986).
Feduchi, E., Alonso, M. A. & Carrasco, L. J. Virol. 63, 1354–1389 (1989).
Zinkernagel, R. M., Rüedi, E., Althage, A., Hengartner, H. & Reimann, G. J. exp. Med. 168, 1187–1192 (1988).
Pfeffer, K. et al. Cell 73, 457–467 (1993).
Adra, C. N., Boer, P. H. & McBurney, M. W. Gene 60, 65–74 (1987).
Rothe, J. G., Brockhaus, M., Gentz, R. & Lesslauer, W. Immunogenetics 34, 338–340 (1991).
Gehr, G., Gentz, R., Brockhaus, M., Loetscher, H. R. & Lesslauer, W. J. Immun. 149, 911–917 (1992).
Doetschmann, T. et al. Nature 330, 576–578 (1987).
Köntgen, F., Süss, G., Stewart, C., Steinmetz, M. & Bluethmann, H. Intern Immun. (in the press).
Blanden, R. V. & Langman, R. E. Scand. J. Immun. 1, 379–391 (1972).
Leist, T. P., Eppler, M. & Zinkernagel, R. M. J. Virol. 63, 2813–2819 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rothe, J., Lesslauer, W., Lötscher, H. et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364, 798–802 (1993). https://doi.org/10.1038/364798a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/364798a0
This article is cited by
-
Advancing Biologic Therapy for Refractory Autoimmune Hepatitis
Digestive Diseases and Sciences (2022)
-
Congenital iRHOM2 deficiency causes ADAM17 dysfunction and environmentally directed immunodysregulatory disease
Nature Immunology (2022)
-
Fundamentally different roles of neuronal TNF receptors in CNS pathology: TNFR1 and IKKβ promote microglial responses and tissue injury in demyelination while TNFR2 protects against excitotoxicity in mice
Journal of Neuroinflammation (2021)
-
Fibroblastic reticular cell lineage convergence in Peyer’s patches governs intestinal immunity
Nature Immunology (2021)
-
Batf2 differentially regulates tissue immunopathology in Type 1 and Type 2 diseases
Mucosal Immunology (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.